- Home
- BAND vs LXRX Comparison
BAND vs LXRX Comparison
Compare BAND & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAND
- LXRX
- Stock Information
- Founded
- BAND 2000
- LXRX 1995
- Country
- BAND United States
- LXRX United States
- Employees
- BAND N/A
- LXRX N/A
- Industry
- BAND Computer Software: Prepackaged Software
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- BAND Technology
- LXRX Health Care
- Exchange
- BAND Nasdaq
- LXRX Nasdaq
- Market Cap
- BAND 431.0M
- LXRX 428.8M
- IPO Year
- BAND 2017
- LXRX 2000
- Fundamental
- Price
- BAND $14.85
- LXRX $1.13
- Analyst Decision
- BAND Buy
- LXRX Buy
- Analyst Count
- BAND 6
- LXRX 5
- Target Price
- BAND $20.80
- LXRX $3.23
- AVG Volume (30 Days)
- BAND 202.6K
- LXRX 2.3M
- Earning Date
- BAND 07-29-2025
- LXRX 08-06-2025
- Dividend Yield
- BAND N/A
- LXRX N/A
- EPS Growth
- BAND N/A
- LXRX N/A
- EPS
- BAND N/A
- LXRX N/A
- Revenue
- BAND $758,106,000.00
- LXRX $58,432,000.00
- Revenue This Year
- BAND $2.48
- LXRX N/A
- Revenue Next Year
- BAND $13.24
- LXRX N/A
- P/E Ratio
- BAND N/A
- LXRX N/A
- Revenue Growth
- BAND 14.51
- LXRX 1504.83
- 52 Week Low
- BAND $11.33
- LXRX $0.28
- 52 Week High
- BAND $23.00
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- BAND 54.92
- LXRX 51.37
- Support Level
- BAND $13.71
- LXRX $1.12
- Resistance Level
- BAND $14.84
- LXRX $1.23
- Average True Range (ATR)
- BAND 0.48
- LXRX 0.07
- MACD
- BAND 0.13
- LXRX -0.01
- Stochastic Oscillator
- BAND 96.28
- LXRX 50.00
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.